General Information


We are a commercial-stage bioelectronic medicine company with a platform non-invasive vagus nerve stimulation therapy initially focused on neurology and rheumatology. Our therapy, gammaCore, has pharmacologic effects on the peripheral and central nervous systems, which modulate neurotransmitters and immune function. gammaCore is FDA-cleared for the acute treatment of pain associated with migraine and episodic cluster headache in adults.


Employees: 64
Founded: 2005
Contact Information
Address 150 Allen Rd., Suite 201, Basking Ridge, NJ 07920, US
Phone Number (973) 290-0097
Web Address http://www.electrocore.com
View Prospectus: Electrocore
Financial Information
Market Cap $426.4mil
Revenues $847.2 mil (last 12 months)
Net Income $-39.2 mil (last 12 months)
IPO Profile
Symbol ECOR
Exchange NASDAQ
Shares (millions): 5.2
Price range $15.00 - $15.00
Est. $ Volume $78.0 mil
Manager / Joint Managers Evercore ISI/ Cantor/ JMP Securities
CO-Managers BTIG
Expected To Trade: 6/22/2018
Status: Priced
Quiet Period Expiration Date:
Lock-Up Period Expiration Date:
SCOOP Rating
Rating Change